Who owns OKYO PHARMA LTD?
- Ticker: OKYO
- CUSIP Number: g6724l116
Tip: Access positions for across all investors
Analyze quarterly positions in Okyo Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Okyo Pharma stock
Who bought or sold OKYO PHARMA LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Woodline Partners | 3.7M | $5.9M | 100% | Mar 2026 |
|
| Maven Securities | 1.2M | $1.9M | 100% | Mar 2026 |
|
| Stonepine Capital Management | 850k | $1.4M | 100% | Mar 2026 |
|
| Balyasny Asset Management | 585k | $942k | 100% | Mar 2026 |
|
| UBS Group | 60k | $96k | 2651% | Mar 2026 |
|
| XTX Topco | 38k | $61k | 114% | Mar 2026 |
|
| HPM Partners | 13k | $21k | 0% | Mar 2026 |
|
| Geode Capital Management | 12k | $20k | 0% | Mar 2026 |
|
| Dauntless Investment Group | 3.8k | $6.1k | -99% | Mar 2026 |
|
| EFG International | 923.00 | $1.5k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 152.00 | $244.005600 | 0% | Mar 2026 |
|
| Morgan Stanley | 10.00 | $16.000000 | 0% | Mar 2026 |
|
Who sold out of Okyo Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Dec 2025 | 138k | $286k |
| Wealth Enhancement Advisory Services | Dec 2025 | 10k | $21k |